2023
DOI: 10.1097/j.pain.0000000000002888
|View full text |Cite
|
Sign up to set email alerts
|

Research objectives and general considerations for pragmatic clinical trials of pain treatments: IMMPACT statement

Abstract: Many questions regarding the clinical management of people experiencing pain and related health policy decision-making may best be answered by pragmatic controlled trials. To generate clinically relevant and widely applicable findings, such trials aim to reproduce elements of routine clinical care or are embedded within clinical workflows. In contrast with traditional efficacy trials, pragmatic trials are intended to address a broader set of external validity questions critical for stakeholders (clinicians, he… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
7
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 8 publications
(7 citation statements)
references
References 143 publications
0
7
0
Order By: Relevance
“…The authors should be expected to screen previous literature to appraise what is already known about a given intervention before attempting a pRCTs. Ultimately, a sound background should be provided alongside the rationale for attempting a pragmatic trial [90]. Such rationale might include existing mechanistic experiments and placebo-or sham-controlled e cacy trials, suggesting that the intervention has the desired physiological effects and e cacy [91].…”
Section: Discussionmentioning
confidence: 99%
“…The authors should be expected to screen previous literature to appraise what is already known about a given intervention before attempting a pRCTs. Ultimately, a sound background should be provided alongside the rationale for attempting a pragmatic trial [90]. Such rationale might include existing mechanistic experiments and placebo-or sham-controlled e cacy trials, suggesting that the intervention has the desired physiological effects and e cacy [91].…”
Section: Discussionmentioning
confidence: 99%
“…In the context of pain, novel approaches that go past traditional efficacy trials may be needed. For example, pragmatic trials that consider a more comprehensive set of external validity questions critical for patients, clinicians, and policy makers may prove useful (Hohenschurz-Schmidt et al, 2023). The use of real-world data, or health data that is routinely collected for research purposes, is another novel approach.…”
Section: Treatmentmentioning
confidence: 99%
“…The use of real-world data, or health data that is routinely collected for research purposes, is another novel approach. A systematic review of this methodology demonstrates that, if rigorous quality standards are met, this approach can be valuable in generating highquality evidence that goes beyond clinical trials (Vollert et al, 2023). Finally, emerging technologies such as machine learning can help construct prognostic profiles (Zmudzki and Smeets, 2023) and therefore aid in treatment personalization and outcome optimization.…”
Section: Treatmentmentioning
confidence: 99%
“…• Conducting systematic reviews and meta-analyses : the Cochrane Handbook for Systematic Reviews of Interventions [ 102 ] provides extensive methodological guidelines. • Designing pragmatic trials : a dedicated IMMPACT statement [ 103 ] summarises relevant methodological considerations for the design and conduct of pragmatic trials of pain interventions. • Enhancing control interventions : the CoPPS statement [ 85 ] makes “recommendations for designing, conducting, and reporting control interventions” that are relevant for SMT research.…”
Section: Main Textmentioning
confidence: 99%